Wang Zhong is the first generation of neurosurgeons trained by New China and one of the pioneers of neurosurgery in China. During his half-century medical career, he has made innovative contributions to the development and growth of China's neurosurgery and to the world.
He was the first to put forward the viewpoint of "brainstem and spinal cord have plasticity" and summarized a set of theories and methods of different surgical approaches for different brainstem tumors, which played an important role in opening up the "forbidden zone" in the medical field, i.e. brainstem tumor surgery. These theoretical points played a decisive role in opening up the "forbidden zone" in the medical field --- brainstem tumor surgery. Under the guidance of this theory, more than 1,100 surgeries have been performed so far, with a mortality rate of less than 1.0%, and the quality and quantity of surgeries are among the world's leading.
Based on the discovery of the plasticity of the brainstem, he studied the structure and function of the spinal cord, and through numerous animal experiments and decades of clinical practice, came to the conclusion that "the spinal cord is also plastic to chronic tumor compression". So far, he has led a team that has performed more than 2,500 intramedullary tumor surgeries without a single case of death or surgical disability, and the level of surgery is among the world's leading. His idea of "spinal cord ischemia pre-adaptation" has played a key role in preventing postoperative paralysis of intramedullary tumors, and the quality of patient's life has been greatly improved.
He was the first to put forward the idea that "large hemangioblastoma can produce normal perfusion pressure breakthrough after surgery", and utilized preoperative embolization of tumor-supporting blood vessels, suboperative hypothermia and other measures to effectively prevent the occurrence of the "normal perfusion breakthrough phenomenon", which reduced the surgical mortality rate to 4.3%, and the patient's survival quality has been greatly improved. The mortality rate of the operation was reduced to 4.3%, and the disability rate of the operation was greatly reduced, while the mortality rate of the operation was reported to be as high as 24% by the International Comprehensive Group.
In the 1950s, in order to improve the level of neurosurgery, Wang Zhong studied cerebral angiography in the absence of information and equipment, endured large doses of radiation, six times pneumonia, and suffered serious physical damage, accumulated more than 2,500 cases, and compiled China's first neurosurgical monograph, "Cerebral Angiography", which was awarded the National Science Congress Prize. In the 1960s, he was the first to adopt and promote microscopic neurosurgical techniques in China, performing more than 1,000 aneurysm surgeries and reducing the mortality rate of the disease from 10% to less than 2%. In the 1970s, he was the first to carry out and promote cranial microsurgery in China, and for the first time, he completely removed a pituitary adenoma with preservation of the patient's body using microsurgical techniques.
He was the first surgeon in China to perform and promote cranial microsurgery, which was the first time to use microsurgical techniques to completely remove a pituitary adenoma and preserve the patient's normal pituitary functions.
He led his team to establish a new method of neurosurgery, solved many worldwide problems in the field of neurosurgery, greatly improved the efficacy of difficult brain diseases such as brainstem tumors, intraspinal tumors, thalamic tumors, and tumors of the midline of the base of the skull, so that the patients basically enjoy the quality of life of a normal person after the operation, and brought China's overall level of neurosurgery into the advanced ranks of the world.
Academician Wang Zhongzhong took the lead in organizing the "Neurosurgery Branch of the Chinese Medical Association", founding the "Chinese Journal of Neurosurgery", and standardizing the diagnostic criteria for neurosurgical diseases in China. He founded and expanded the Beijing Institute of Neurosurgery and Tiantan Hospital, which became the largest neurosurgery base in Asia. He led his students to successfully develop seven materials such as domestic catheters and balloon embolization, which filled the gaps in this area in China. He led and organized the investigation of neuroepidemiology in China, which provided the basis for the Party and the State to formulate preventive policies.
Over the past 60 years, he has published more than 290 academic papers and more than 20 monographs; he has been honored with 66 scientific research awards, including 8 national awards and 30 awards at the ministerial and municipal levels. he was honored with the "Ho Leung Ho Lee Award for Scientific and Technological Achievement" in 1997, and was awarded the highest award in the national health system in 2000 In 1997, he was awarded the "He Liang He Li Award for Scientific and Technological Achievement", in 2000, he was awarded the highest award in the national health system, "Bai Qiu En Medal", and in 2001, he was awarded the "Highest Medal of Honor" by the World Federation of Neurosurgical Societies. In 2006, he was honored with the "Leadership Award for Contributions to the Advancement of Skull Base Surgery" at the Asian University Congress of Skull Base Neurosurgery.
In recent years, he founded the World Chinese Neurosurgical Association and successfully held three World Chinese Neurosurgical Conferences. Today, he is still working on the front line of medical treatment, teaching and research, and is striving for his patients, students and medical career.